Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Piero Picci

7PUBLICATIONS
60CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Intensive careHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Aug 18, 2025
Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials.

Emanuela Palmerini, Cristina Meazza, Angela Tamburini

|Jul 02, 2021
Front-Line Window Therapy with Temozolomide and Irinotecan in Patients with Primary Disseminated Multifocal Ewing Sarcoma: Results of the ISG/AIEOP EW-2 Study.

Sebastian Dorin Asaftei, Nadia Puma, Anna Paioli

|Jul 02, 2021
Whole Lung Irradiation after High-Dose Busulfan/Melphalan in Ewing Sarcoma with Lung Metastases: An Italian Sarcoma Group and Associazione Italiana Ematologia Oncologia Pediatrica Joint Study.

Massimo E Abate, Silvia Cammelli, Letizia Ronchi

|Apr 03, 2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.

Emanuela Palmerini, Roberta Sanfilippo, Giovanni Grignani

|Nov 04, 2020
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series.

Emanuela Palmerini, Elisabetta Setola, Giovanni Grignani

|Oct 07, 2020
Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases.

E M Schutgens, P Picci, D Baumhoer

Pageof 2

Frequent Collaborators

5 joint publications

Emanuela Palmerini

4 joint publications

Giovanni Grignani

3 joint publications

Sebastian Dorin Asaftei

3 joint publications

Elisa Carretta

3 joint publications

Franca Fagioli

2 joint publications

Toni Ibrahim

2 joint publications

Alessandra Longhi

2 joint publications

Elisabetta Setola

1 joint publications

D Baumhoer

1 joint publications

P C W Hogendoorn

Frequent Collaborators

5 joint publications

Emanuela Palmerini

4 joint publications

Giovanni Grignani

3 joint publications

Sebastian Dorin Asaftei

3 joint publications

Elisa Carretta

Top Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>

Published on : Mar 18, 2014

12.9K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

18.6K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

See more related videos

Top Related Videos

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>
08:04

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells <em>In Vitro</em>

Published on : Mar 18, 2014

12.9K
The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
08:00

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on : Apr 16, 2019

18.6K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on : Apr 01, 2015

See more related videos